This article will be updated throughout the day, so check back often for more daily updates. The markets are cautious as of ...

UnitedHealth Is One of the Worst S&P 500 Stocks In 2025. Here's Why It's Having an Even Bigger Impact on the Dow Jones.

Companies are seeking vast amounts of capital for a wide range of artificial intelligence-linked projects, including building data centers and fiber optic networks, creating demand for funding in ...

In a new note titled “What to do after the rally,” Goldman Sachs global equity strategist Peter Oppenheimer poses that ...

Wall Street's AI arms race is underway. Goldman Sachs is equipping thousands of staffers with custom AI tools — here's a look ...

Goldman Sachs a GARP stock offers strong growth, value, and dividends, with profits doubling YOY and new catalysts boosting ...

Punchbowl News, a DC news outlet started by former Politico journalists, has allegedly allowed corporate sponsors to buy editorial features for hundreds of thousands of dollars, according to ...

Detailed price information for Envista Holdings Corp (NVST-N) from The Globe and Mail including charting and trades.

Lavina Talukdar; Senior Vice President & Head of Investor Relations; Moderna Inc. Stephane Bancel; Chief Executive Officer, Director; Moderna Inc. James Mock; Chief ...

Goldman Sachs CEO David Solomon cautioned about Trump's tariffs, noting CEOs are hesitant to invest due to heightened uncertainty. He observed companies are tightening budgets and potentially ...

Q1 2025 Management View CEO Stephane Bancel highlighted that Q1 revenues were $0.1 billion, with a net loss of $1 billion, reflecting the seasonal nature of the company’s respiratory vaccine business.

Meanwhile, another foreign brokerage, Goldman Sachs continued with its 'sell' stance on the counter with the target pegged at Rs 550, implying 21 per cent potential downside. The brokerage held that ...